Erratum to: Adv Ther (2015) 32:216–227 DOI 10.1007/s12325-015-0189-1
The authors wish to notify the readers that although the above mentioned article addressed different research questions and therefore evaluated different endpoints, the study employed a similar study design using the same sample of patients with nonvalvular atrial fibrillation (NVAF) treated with either rivaroxaban or warfarin as the study sample reported in a study published in Clinical Therapeutics by the present authors [1]. The current research focused on the economic evaluation of the effect of rivaroxaban versus warfarin among matched cohorts. Because the two articles were accepted for publication at the same time, the authors want to cross-reference both articles in the current addendum for clarity and transparency.
Reference
Laliberté F, Cloutier M, Crivera C, et al. Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users. Clin Ther. 2015;37(3):554–62.
Open Access
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s12325-015-0189-1.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Laliberté, F., Cloutier, M., Crivera, C. et al. Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users. Adv Ther 32, 387 (2015). https://doi.org/10.1007/s12325-015-0202-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-015-0202-8